Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
| NAV2024-04-24 | Chg.-0.6700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 311.0900EUR | -0.21% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.24 | 8.73 | -8.18 | 11.89 | -1.92 | 3.11 | -10.47 | 12.83 | -2.22 | - |
| 2017 | 3.03 | 8.72 | -0.49 | -0.67 | -5.96 | 7.91 | -0.89 | 5.99 | 1.53 | -5.17 | -2.11 | 0.80 | +12.13% |
| 2018 | 2.91 | -2.52 | -2.89 | -1.42 | 8.33 | 0.84 | 4.25 | 4.77 | -1.87 | -11.81 | 4.26 | -9.14 | -6.05% |
| 2019 | 12.77 | 4.42 | 0.90 | -4.71 | -3.87 | 7.14 | 0.09 | -1.23 | -3.48 | 8.72 | 13.36 | 1.02 | +38.52% |
| 2020 | -4.00 | -0.60 | -4.83 | 12.62 | 7.87 | 0.37 | -7.82 | -0.23 | 2.77 | -1.95 | 6.65 | 0.73 | +10.25% |
| 2021 | 2.59 | -2.45 | -1.09 | 0.34 | -3.37 | 9.30 | -1.40 | 4.43 | -2.41 | 0.36 | -1.64 | 1.42 | +5.54% |
| 2022 | -9.24 | -1.70 | 7.12 | -2.10 | -5.38 | 6.12 | 7.42 | 3.02 | 0.75 | 5.62 | 1.98 | -6.23 | +5.80% |
| 2023 | 1.20 | -3.34 | -2.09 | 0.70 | 2.65 | -0.83 | -1.56 | 1.42 | -2.03 | -5.90 | 2.91 | 12.30 | +4.44% |
| 2024 | 3.27 | 1.79 | 0.23 | -5.31 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.17% | 18.32% | 15.96% | 20.22% | 23.16% |
| Sharpe ratio | -0.29 | 1.23 | 0.14 | 0.06 | 0.25 |
| Best month | +12.30% | +12.30% | +12.30% | +12.30% | +13.36% |
| Worst month | -5.31% | -5.90% | -5.90% | -9.24% | -9.24% |
| Maximum loss | -9.45% | -9.45% | -13.73% | -19.49% | -27.31% |
| Outperformance | -2.53% | - | -0.31% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,943.7300 | +2.27% | +0.54% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 210.9900 | +5.17% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,949.3500 | 0.00% | -6.46% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,121.0901 | +5.45% | +13.29% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,280.1299 | +2.41% | +10.79% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 345.0800 | +3.12% | +14.58% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 311.0900 | +6.15% | +15.92% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 190.8100 | -1.68% | -7.53% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,743.4100 | +3.13% | +3.31% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 141.6200 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 567.4900 | +1.60% | -1.20% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,318.0000 | +2.15% | +0.17% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 187.0400 | -0.18% | -6.61% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 194.9200 | +0.68% | -4.32% | |
| Candriam Equities L Biotech.R US... | reinvestment | 252.7500 | +2.87% | +2.54% | |
| Candriam Equities L Biotech.C US... | reinvestment | 796.3700 | +1.97% | +0.05% | |
| Candriam Equities L Biotech.C US... | paying dividend | 731.5500 | +1.94% | -0.04% |
Performance
| YTD | -0.23% | ||
|---|---|---|---|
| 6 Months | +12.43% | ||
| 1 Year | +6.15% | ||
| 3 Years | +15.92% | ||
| 5 Years | +57.86% | ||
| Since start | +107.39% | ||
| Year | |||
| 2023 | +4.44% | ||
| 2022 | +5.80% | ||
| 2021 | +5.54% | ||
| 2020 | +10.25% | ||
| 2019 | +38.52% | ||
| 2018 | -6.05% | ||
| 2017 | +12.13% | ||
